9% growth masks 250bps profit drop; margin recovery betting on Q2-Q3 realization
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Q1 FY27 margin 14.6% vs 17.8% prior year; PAT -26.5%; price hedges into Q2. Historical 14-15% vs 18% guidance is a credibility gap.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Borosil delivered 9% revenue growth on volume while PAT fell 26.5%, margins compressed 320bps EBITDA due to West Asia costs and Hydra weakness. Management guides 18% EBITDA for FY27 contingent on price realization in Q2-Q3, but at Q1's 14.6% achieved margin, this requires ~20% for 9 months—a 560bps stretch over historical 14-15%. Solar benefits (₹27-28 Cr EBITDA savings) and multi-year capacity expansions are tangible, but near-term execution risk is high.
₹253.6 Cr
Revenue · +9% YoY₹12.8 Cr
Reported PAT · −26.5% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Steady growth against challenging market conditions
OVERSTATED9% YoY revenue, -11.3% QoQ, PAT down 26.5% despite revenue growth
West Asia conflict impact ~INR10 Cr
METEBITDA fell 4.3 Cr total YoY; fuel impact stated 6 Cr Opal + 2.5 Cr boro before reductions
Price hikes 5-7% taken in Q1
PartialOnly ~INR2 Cr realized of estimated INR12 Cr cost impact; bulk realization in Q2 onwards
Hydra plant producing saleable material from 30 June 2026
METCommercial production declared 30 June on 2 double-wall lines; third line Q2 FY27
Glassware segment double-digit growth, volume-led
MET16.8% growth (65.6 vs 56.2 Cr); CFO confirmed volume-led with lag on price realization
Earnings quality
What changed since the last call
FY27 EBITDA margin guidance 18%
NeutralPrior: medium-term 18-20%. New: FY27 18% (excluding West Asia). Q1 delivered 14.6%. Qualifier added ('barring conflict'); realization pushed to Q2-Q3. No numeric cut, but confidence erosion visible.
Hydra investment accelerated
UpgradeStylenest (Hydra subsidiary) plant now operational with 2 double-wall lines (June 2026) + 3rd Q2 FY27. Prior guidance was vague; concrete commissioning is positive, though volume contribution in Q1 was minimal (non-glassware +4.2% only).
Solar Phase 3 commissioned Q1 FY27
Upgrade20 MW with battery storage added in Q1; total solar now 61% of energy. ₹27-28 Cr EBITDA benefit claimed. Prior: solar was 2 plants (8.6 + 7.2 MW). Tangible structural margin tailwind, though not yet reflected in Q1 EBITDA.
Capex guidance increased to ₹150 Cr
UpgradeFrom implied ₹125-136 Cr (historical). Bharuch glassware (₹42 Cr) + borosilicate furnace (₹50 Cr) + solar + maintenance. Longer runway for growth capex, but ROCE pressure near-term.
ROCE target revised to 20-22% medium-term
NeutralFrom implied improvement path. Analyst challenge: current 11%, PAT down 26.5%, capital employed rising. No timeframe ('medium-term') or bridge articulated; management dodged specificity. Aspirational, not committed.
The Q&A
Analysts (Anu Parakh, Jasdeep Walia, Devavrat Jatia) pressed hard on: 18% margin guidance vs historical 14-15%, ROCE weakness despite capex, Chinese dumping impact on normalized borosilicate margins, and ROCE bridge from 11% to 20%+. Management absorbed pressure defensively, repeatedly hedging ('barring West Asia', 'medium-term aspiration'), refusing to quantify category-wise margins or price/volume split, and deferring specifics to Q2-Q3 realization. No concessions; tone stiffened under scrutiny.
Glassware price vs volume — Anu Parakh, Anand Rathi
AnsweredVolume-led; price realization lags to Q2. Price hikes 5-7% taken April, but execution starts mid-May; realization Q2 onwards.
West Asia cost impact — Anu Parakh, Anand Rathi
Answered~₹2 Cr realized vs ~₹12 Cr cost impact; bulk in Q2-Q3. Fuel (packaging) largest component.
Opalware margin pressure — Anu Parakh, Anand Rathi
AnsweredYes, margins under pressure from West Asia conflict across all categories. Sustainable 18-20% EBITDA (overall) excluding conflict.
FY27 EBITDA margin — Akshat Mehta, Seven Rivers
Answered18% EBITDA for FY27 (barring West Asia). Capex ₹125-150 Cr (glassware projects, solar, maintenance).
Chinese dumping status — Jasdeep Walia, Clockvine Capital
AnsweredDumping continues despite rupee depreciation and shipping freight hikes. No visible relief. Anti-dumping investigation ongoing.
Normalized borosilicate margins — Jasdeep Walia, Clockvine Capital
DodgedNot answering category-wise margins. Glassware market expansion objective differs from competitors. Investigation outcome key.
Solar savings split — Jasdeep Walia, Clockvine Capital
PartialBoth; mix depends on market behavior. Leverage for competitiveness and margin improvement.
Margin guidance bridge — Anu Parakh, Anand Rathi
Partial18% is steady-state without West Asia conflict. Price realization + solar savings + high-realization SKU mix + cost discontinuations.
ROCE weakness — Anu Parakh, Anand Rathi
PartialCapex is multi-year; ROCE improves as utilization and margins scale. Target 20-24% ROCE medium-term via capacity expansion and inventory normalization.
Capex allocation rationale — Devavrat Jatia, Seven Rivers
PartialCapex cycles are multi-year; 21% CAGR over 10 years validates growth. BIS transition required capex. Margins will improve; ROCE target 20-22% medium-term.
Exclusive store capex — Bhavin Rupani, Investec
AnsweredConsumer brand experience & interaction. ₹40-50 Lakh per store. No store count target yet; learning phase; Jaipur next; scale to be decided.
Gas cost contribution — Bhavin Rupani, Investec
AnsweredFY26: 2.9% of sales; FY27: 5.8%. Opalware steady 4%, glassware 5.5% (pre-inflation). April price hike, May execution, Q2 realization.
ROCE to 22% bridge — Devavrat Jatia, Seven Rivers
DodgedCapacity utilization scaling, margin improvement, fixed-cost leverage, depreciation normalization. No specifics on timeframe ('medium-term aspiration').
Hydra production timeline — Pranay Chatterjee, Burman Capital
AnsweredCommercial production declared 30 June 2026; already producing saleable material from 2 double-wall lines.
Guidance
Long-term 15-20% YoY revenue CAGR maintained (10-year historic 21% CAGR cited)
MediumQ1 FY27 delivered 9% YoY; well below long-term target. Management frames as 'building market' rather than near-term miss. FY27 specific revenue growth not quantified.
FY27 EBITDA margin ~18% (excluding West Asia conflict impact)
MediumQ1 achieved 14.6%; requires ~19.8% avg Q2-Q4. Price realization (5-7% hikes) expected Q2 onwards. Fuel prices stabilizing; packaging inflation ongoing. Solar ₹27-28 Cr EBITDA benefit. Conditional on market normalization.
Medium-term (2-3yr) 18-20% EBITDA margin range
MediumPrior guidance reaffirmed. Near-term (18% FY27) is lower bound of range. Depends on price realization, capacity utilization, and operational leverage.
FY27 capex ₹125-150 Cr (Bharuch ₹42 Cr, borosilicate ₹50 Cr, solar projects, maintenance opal furnace)
HighProjects detailed and progressing. Bharuch expected Q3 FY27, furnace expansion Q4 FY28. Solar Phase 4 (6.5 MW Borosil + 3-4 MW Stylenest) under evaluation.
Risks the call surfaced
Commodity/input cost volatility
HighQ1 impacted ₹10 Cr (fuel + packaging). Partially offset by 5-7% price hikes, but realization lagged (only ₹2 Cr in Q1). If conflict persists and prices don't pass through, margin compression continues.
Competitive pricing pressure
HighChinese competition in borosilicate glassware dumping continues despite rupee depreciation and shipping cost inflation. Management sees no relief. Risk: normalized borosilicate margins (historically 25-30% expectation) may scale down permanently.
Hydra BIS compliance / supply chain
HighHydra (vacuum-insulated stainless-steel flasks/bottles) faces ongoing BIS compliance headwinds. New Stylenest plant (2 double-wall lines operational June 2026) is solving manufacturing, but category grew only 4.2% in Q1 despite investment. Risk: demand recovery slower than expected; new plant utilization ramping uncertain.
Margin recovery / pricing power
HighManagement guides 18% EBITDA for FY27 contingent on price realization from 5-7% hikes taken in April. However, Q1 realization was only ₹2 Cr of ~₹12 Cr impact. Risk: realization further delayed or incomplete if market resists or competitors undercut.
ROCE & capital allocation efficiency
MediumROCE stuck at 11% (FY26) despite heavy capex cycle (₹150 Cr FY27 planned). PAT fell 26.5% YoY despite 9% revenue growth, signaling capital productivity weakness. New capex (Bharuch, borosilicate, solar) will add depreciation (₹92 Cr FY27) before utilization benefit. Risk: ROCE target of 20-22% (medium-term aspiration) may take 3+ years to realize; investor returns pressured meantime.
Management
Score 5/10. Evasive on hard metrics (category-wise margins, price/volume split specificity, ROCE timeframe). Repeatedly hedged margins as 'excluding West Asia' and 'medium-term aspiration' rather than committing. Multiple connection issues on call. Defensive tone throughout Q&A. Mixed. Solar Phase 3 commissioned on time (Q1 FY27). Hydra plant producing (June 30). Bharuch project on track (Q3 expected). But Hydra category growth (4.2%) and overall PAT decline (-26.5%) signal execution gaps vs prior expectations. Price realization heavily lagged.
1 · Q2 Q3 FY27
Price realization from April-May hikes (5-7%); margin recovery inflection
2 · Q2 FY27
Third Hydra double-wall line commercial; supply constraint relief
3 · Q3 FY27
Bharuch glassware facility commissioning; high-margin in-house production
Solar benefits (₹27-28 Cr EBITDA savings) and multi-year capacity expansions are tangible, but near-term execution risk is high.
Informational and educational content only. Not investment advice.